Home
/
Traws Pharma, Inc.
/
Financials
/
Quarterly
Traws Pharma, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Traws Pharma, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$2.79M
Nov 13, 2025
Q2
2025
Jun 30, 2025
$2.73M
Aug 14, 2025
Q1
2025
Mar 31, 2025
$57.0K
May 15, 2025
Q3
2025
Sep 30, 2024
$57.0K
Nov 13, 2025
Q2
2025
Jun 30, 2024
$57.0K
Aug 14, 2025
Q1
2025
Mar 31, 2024
$56.0K
May 15, 2025
Q3
2024
Sep 30, 2023
$57.0K
Nov 14, 2024
Q2
2024
Jun 30, 2023
$57.0K
Aug 15, 2024
Q1
2024
Mar 31, 2023
$56.0K
May 15, 2024
Q3
2023
Sep 30, 2022
$57.0K
Nov 14, 2023
Q2
2023
Jun 30, 2022
$57.0K
Aug 14, 2023
Q1
2023
Mar 31, 2022
$56.0K
May 15, 2023
Q3
2022
Sep 30, 2021
$57.0K
Nov 14, 2022
Q2
2022
Jun 30, 2021
$57.0K
Aug 15, 2022
Q1
2022
Mar 31, 2021
$56.0K
May 13, 2022
Q3
2021
Sep 30, 2020
$66.0K
Nov 15, 2021
Q2
2021
Jun 30, 2020
$56.0K
Aug 16, 2021
Q1
2021
Mar 31, 2020
$52.0K
May 17, 2021
Q3
2020
Sep 30, 2019
$63.0K
Nov 16, 2020
Q2
2020
Jun 30, 2019
$2.02M
Aug 12, 2020
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$57.0K
Nov 14, 2024
Q3
2024
Sep 30, 2023
$57.0K
Nov 14, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($3.96M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($915.0K)
Aug 14, 2025
Q1
2025
Mar 31, 2025
$21.49M
May 15, 2025
Q3
2025
Sep 30, 2024
($8.48M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($123.14M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($4.98M)
May 15, 2025
Q3
2024
Sep 30, 2023
($4.74M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($4.25M)
Aug 15, 2024
Q3
2019
Sep 30, 2019
($4.60M)
Nov 12, 2019
Q2
2019
Jun 30, 2019
($3.56M)
Aug 14, 2019
Q1
2019
Mar 31, 2019
($7.60M)
May 15, 2019
Q3
2019
Sep 30, 2018
($5.35M)
Nov 12, 2019
Q2
2019
Jun 30, 2018
($4.48M)
Aug 14, 2019
Q1
2019
Mar 31, 2018
($5.09M)
May 15, 2019
Q3
2018
Sep 30, 2017
($6.96M)
Nov 14, 2018
Q2
2018
Jun 30, 2017
($2.58M)
Aug 14, 2018
Q1
2018
Mar 31, 2017
($8.34M)
May 15, 2018
Q3
2017
Sep 30, 2016
($1.60M)
Nov 9, 2017
Q2
2017
Jun 30, 2016
($5.38M)
Aug 14, 2017
Q1
2017
Mar 31, 2016
($7.24M)
May 15, 2017
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($4.06M)
Nov 13, 2025
Q2
2025
Jun 30, 2025
($1.25M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($5.20M)
May 15, 2025
Q3
2025
Sep 30, 2024
($8.54M)
Nov 13, 2025
Q2
2025
Jun 30, 2024
($123.35M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($5.21M)
May 15, 2025
Q3
2024
Sep 30, 2023
($5.09M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($4.61M)
Aug 15, 2024
Q1
2024
Mar 31, 2023
($6.14M)
May 15, 2024
Q3
2023
Sep 30, 2022
($5.64M)
Nov 14, 2023
Q2
2023
Jun 30, 2022
($4.12M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($4.13M)
May 15, 2023
Q3
2022
Sep 30, 2021
($3.99M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($4.65M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($4.10M)
May 13, 2022
Q3
2021
Sep 30, 2020
($6.27M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($7.34M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($5.13M)
May 17, 2021
Q3
2020
Sep 30, 2019
($5.10M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($3.63M)
Aug 12, 2020